TRT9 min read
Why a better DEXA scan is not proof of a better TRT outcome
Lean tissue, strength and daily function are different outcomes. Learn what a DXA change can show—and what it cannot prove about testosterone treatment.
Read articleBlog
Research, explained. Explore peptides, supplements, hormone health, longevity and red light therapy with clear, practical breakdowns of what the studies actually tell us.
Explore the articles
Find a topic you’re curious about and take a closer look.
Peptides9 min read
What the 2025 amycretin trial actually adds
The injected amycretin study produced a striking early weight signal. Its five-part design, intensive monitoring and withdrawals determine what that signal can mean.
Read article
Peptides9 min read
Thymosin beta-4: why eye drops, wound gels and injections differ
Eye drops, gels and intravenous thymosin beta-4 reach different tissues and answer different treatment questions. Here is what the human studies establish.
Read article
Peptides8 min read
Thymosin beta-4 and corneal repair: closure, comfort and vision
Corneal wound closure, comfort, sensation and vision are different outcomes. The SEER-1 eye-drop trial helps explain what thymosin beta-4 has and has not shown.
Read article
Peptides7 min read
GHRP-6 versus GHRP-2: appetite, hormones and clinical evidence
Compare GHRP-6 and GHRP-2 by the outcomes actually studied: hormone responses, appetite, repeated exposure and Japan's pralmorelin diagnostic indication.
Read article
Peptides9 min read
Semax and long-term cognitive safety: what short studies leave unanswered
Short imaging and neurological studies cannot establish the safety of years of cognitive-enhancement use. Here is what they observed and what remains unknown.
Read article
Supplements9 min read
The NAD supplement stack can make the evidence harder to interpret
A NAD stack is a new intervention. Learn what NR–pterostilbene and NR–resveratrol studies actually establish about added benefit, biomarkers and safety.
Read article
Supplements8 min read
Garlic and blood pressure: why the preparation matters
Garlic trials often test aged extracts, not kitchen garlic. Understand blood-pressure changes, responder claims and the preparation behind each result.
Read article
Peptides9 min read
GHK-Cu and the 4,000-genes claim: what gene expression can tell us
Trace GHK’s 4,000-genes claim to its cell-line data and learn why RNA changes, functional cell tests, and human treatment benefits are different evidence.
Read article
Peptides9 min read
CJC-1295 studies were short: what remains unknown about longer use?
Early human studies, overlapping cohorts and mouse pituitary findings leave important questions about prolonged CJC-1295 exposure.
Read article
Supplements9 min read
Apigenin for sleep: why chamomile research does not settle the question
Chamomile tea, whole extracts and isolated apigenin are different exposures. Explore the actual human sleep studies and the limits of the receptor story.
Read article
Supplements9 min read
Colostrum and the gut barrier: what the tests actually measure
Why urine permeability tests, intestinal-cell injury markers and everyday digestive symptoms tell different stories in colostrum research.
Read article422–433 of 600 articles